Skip to main content

Advertisement

Log in

Epidemiology and Prevalence of Azole-Resistant Aspergillus fumigatus: What Is Our Understanding of the Situation?

  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Purpose of the Review

Azole-resistant Aspergillus fumigatus is an emerging clinical problem. Resistance can develop both with clinical exposure and with environmental exposure to azole and azole-like fungicides used against phytopathogens. Here, our current understanding of the epidemiology and prevalence of this emerging problem is reviewed.

Recent Findings

Azole-resistant A. fumigatus is now a worldwide problem, as it has been documented in clinical and environmental samples on all but one continent. Although Europe has been the center of this issue, hotspots are now emerging in Asia. However, there are several limitations to our current understanding of the extent of this problem, including issues with surveillance strategies and our reliance on phenotypic methods for detecting resistance.

Summary

Azole-resistant A. fumigatus is an emerging issue both clinically and in the environment that requires greater attention in order to preserve this very useful class of antifungal agents for the treatment of aspergillosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009;47(10):3271–5. https://doi.org/10.1128/JCM.00854-09.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. 2012;65(5):453–64. https://doi.org/10.1016/j.jinf.2012.08.003.

    Article  PubMed  Google Scholar 

  3. Alastruey-Izquierdo A, Mellado E, Pelaez T, Peman J, Zapico S, Alvarez M, et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother. 2013;57(7):3380–7. https://doi.org/10.1128/AAC.00383-13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lestrade PP, Bentvelsen RG, Schauwvlieghe A, Schalekamp S, van der Velden W, Kuiper EJ, et al. Voriconazole Resistance and Mortality in Invasive Aspergillosis: a multicenter retrospective cohort study. Clin Infect Dis. 2019;68(9):1463–71. https://doi.org/10.1093/cid/ciy859.

    Article  CAS  PubMed  Google Scholar 

  5. Resendiz-Sharpe A, Mercier T, Lestrade PPA, van der Beek MT, von dem Borne PA, Cornelissen JJ, et al. Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. J Antimicrob Chemother. 2019;74(9):2759–66. https://doi.org/10.1093/jac/dkz258.

    Article  CAS  PubMed  Google Scholar 

  6. van Paassen J, Russcher A, In ‘t Veld van Wingerden AW, Verweij PE, Kuijper EJ. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013. Euro Surveill. 2016;21(30):30. https://doi.org/10.2807/1560-7917.ES.2016.21.30.30300.

    Article  Google Scholar 

  7. Chryssanthou E. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole. Scand J Infect Dis. 1997;29(5):509–12. https://doi.org/10.3109/00365549709011864.

    Article  CAS  PubMed  Google Scholar 

  8. Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 1997;41(6):1364–8. https://doi.org/10.1128/AAC.41.6.1364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother. 2010;65(10):2116–8. https://doi.org/10.1093/jac/dkq279.

    Article  CAS  PubMed  Google Scholar 

  10. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, et al. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis. 2009;15(7):1068–76. https://doi.org/10.3201/eid1507.090043.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008;5(11):e219. https://doi.org/10.1371/journal.pmed.0050219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE, et al. Triazole resistance surveillance in Aspergillus fumigatus. Med Mycol. 2018;56(suppl_1):83–92. https://doi.org/10.1093/mmy/myx144.

    Article  CAS  PubMed  Google Scholar 

  13. Meis JF, Chowdhary A, Rhodes JL, Fisher MC, Verweij PE. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos Trans R Soc Lond B Biol Sci. 2016;371(1709):20150460. https://doi.org/10.1098/rstb.2015.0460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wiederhold NP, Verweij PE. Aspergillus fumigatus and pan-azole resistance: who should be concerned? Curr Opin Infect Dis. 2020;33(4):290–7. https://doi.org/10.1097/QCO.0000000000000662.

    Article  CAS  PubMed  Google Scholar 

  15. Buil JB, Hare RK, Zwaan BJ, Arendrup MC, Melchers WJG, Verweij PE. The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus. PLoS Pathog. 2019;15(8):e1007858. https://doi.org/10.1371/journal.ppat.1007858.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL. Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol. 2001;39(7):2431–8. https://doi.org/10.1128/JCM.39.7.2431-2438.2001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother. 2004;48(7):2747–50. https://doi.org/10.1128/AAC.48.7.2747-2750.2004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Melchers WJ, Verweij PE, Cuenca-Estrella M, et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother. 2007;51(6):1897–904. https://doi.org/10.1128/AAC.01092-06.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Nywening AV, Rybak JM, Rogers PD, Fortwendel JR. Mechanisms of triazole resistance in Aspergillus fumigatus. Environ Microbiol. 2020;22(12):4934–52. https://doi.org/10.1111/1462-2920.15274. Thorough review on the mechanisms of azole resistance in Aspergillus fumigatus.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med. 2007;356(14):1481–3. https://doi.org/10.1056/NEJMc061720.

    Article  CAS  PubMed  Google Scholar 

  21. Meneau I, Sanglard D. Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates. Med Mycol. 2005;43(Suppl 1):S307–11. https://doi.org/10.1080/13693780500090826.

    Article  CAS  PubMed  Google Scholar 

  22. Dudakova A, Spiess B, Tangwattanachuleeporn M, Sasse C, Buchheidt D, Weig M, et al. Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species. Clin Microbiol Rev. 2017;30(4):1065–91. https://doi.org/10.1128/CMR.00095-16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Toda M, Beer KD, Kuivila KM, Chiller TM, Jackson BR. Trends in Agricultural triazole fungicide use in the United States, 1992–2016 and possible implications for antifungal-resistant fungi in human disease. Environ Health Perspect. 2021;129(5):55001. https://doi.org/10.1289/EHP7484.

    Article  CAS  PubMed  Google Scholar 

  24. Gsaller F, Hortschansky P, Furukawa T, Carr PD, Rash B, Capilla J, et al. Correction: Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT Binding Complex. PLoS Pathog. 2016;12(12):e1006106. https://doi.org/10.1371/journal.ppat.1006106.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gsaller F, Hortschansky P, Furukawa T, Carr PD, Rash B, Capilla J, et al. Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT Binding Complex. PLoS Pathog. 2016;12(7):e1005775. https://doi.org/10.1371/journal.ppat.1005775.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hare RK, Gertsen JB, Astvad KMT, Degn KB, Lokke A, Stegger M, et al. In vivo selection of a unique tandem repeat mediated azole resistance mechanism (TR(120)) in Aspergillus fumigatus cyp51A. Denmark Emerg Infect Dis. 2019;25(3):577–80. https://doi.org/10.3201/eid2503.180297.

    Article  CAS  PubMed  Google Scholar 

  27. Amona FM, Oladele RO, Resendiz-Sharpe A, Denning DW, Kosmidis C, Lagrou K, et al. Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review. Med Mycol. 2022;60(8):myac059. https://doi.org/10.1093/mmy/myac059. Thorough and recent review on the prevalence of azole-resistant A. fumigatus in Africa.

    Article  CAS  PubMed  Google Scholar 

  28. Prigitano A, Esposto MC, Romano L, Auxilia F, Tortorano AM. Azole-resistant Aspergillus fumigatus in the Italian environment. J Glob Antimicrob Resist. 2019;16:220–4. https://doi.org/10.1016/j.jgar.2018.10.017.

    Article  PubMed  Google Scholar 

  29. Engel TGP, Erren E, Vanden Driessche KSJ, Melchers WJG, Reijers MH, Merkus P, et al. Aerosol transmission of Aspergillus fumigatus in cystic fibrosis patients in the Netherlands. Emerg Infect Dis. 2019;25(4):797–9. https://doi.org/10.3201/eid2504.181110. Clinical study in cystic fibrosis patients suggesting that Aspergillus species could possibly be transmitted for patient to environment or from patient to patient.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lemaire B, Normand AC, Forel JM, Cassir N, Piarroux R, Ranque S. Hospitalized patient as source of Aspergillus fumigatus, 2015. Emerg Infect Dis. 2018;24(8):1524–7. https://doi.org/10.3201/eid2408.171865.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gonzalez-Jimenez I, Lucio J, Amich J, Cuesta I, Sanchez Arroyo R, Alcazar-Fuoli L, et al. A Cyp51B mutation contributes to azole resistance in Aspergillus fumigatus. J Fungi (Basel). 2020;6(4):315. https://doi.org/10.3390/jof6040315.

    Article  CAS  PubMed  Google Scholar 

  32. van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, et al. Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis. 2015;21(6):1041–4. https://doi.org/10.3201/eid2106.140717.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Macedo D, Leonardelli F, Gamarra S, Garcia-Effron G. Emergence of triazole resistance in Aspergillus spp. in Latin America. Curr Fungal Infect Rep. 2021;15(3):93–103. https://doi.org/10.1007/s12281-021-00418-6. Thorough and recent review on the prevalence of azole-resistant A. fumigatus in South America as well as mechanisms of resistance.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Singh A, Sharma B, Mahto KK, Meis JF, Chowdhary A. High-frequency direct detection of triazole resistance in Aspergillus fumigatus from patients with chronic pulmonary fungal diseases in India. J Fungi (Basel). 2020;6(2):67. https://doi.org/10.3390/jof6020067. Important study demonstrating the understimation of azole resistance when culture are relied upon and the need for more evaluations using molecular methods for detection of azole resistance.

    Article  CAS  PubMed  Google Scholar 

  35. Vergidis P, Moore CB, Novak-Frazer L, Rautemaa-Richardson R, Walker A, Denning DW, et al. High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum. Clin Microbiol Infect. 2020;26(7):935–40. https://doi.org/10.1016/j.cmi.2019.11.019.

    Article  CAS  PubMed  Google Scholar 

  36. Badali H, Canete-Gibas C, McCarthy D, Patterson H, Sanders C, David MP, et al. Species distribution and antifungal susceptibilities of Aspergillus section fumigati isolates in clinical sampleS from the United States. J Clin Microbiol. 2022;60(5):e0028022. https://doi.org/10.1128/jcm.00280-22.

    Article  CAS  PubMed  Google Scholar 

  37. Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother. 2011;55(9):4465–8. https://doi.org/10.1128/AAC.00185-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Pfaller MA, Carvalhaes CG, Messer SA, Rhomberg PR, Castanheira M. In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years. Diagn Microbiol Infect Dis. 2021;101(3):115473. https://doi.org/10.1016/j.diagmicrobio.2021.115473.

    Article  CAS  PubMed  Google Scholar 

  39. Vermeulen E, Maertens J, Schoemans H, Lagrou K. Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill. 2012;17(48):20326.

    Article  PubMed  Google Scholar 

  40. van der Linden JW, Camps SM, Kampinga GA, Arends JP, Debets-Ossenkopp YJ, Haas PJ, et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis. 2013;57(4):513–20. https://doi.org/10.1093/cid/cit320.

    Article  CAS  PubMed  Google Scholar 

  41. Choukri F, Botterel F, Sitterle E, Bassinet L, Foulet F, Guillot J, et al. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France. Med Mycol. 2015;53(6):593–6. https://doi.org/10.1093/mmy/myv029.

    Article  CAS  PubMed  Google Scholar 

  42. Bader O, Weig M, Reichard U, Lugert R, Kuhns M, Christner M, et al. cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother. 2013;57(8):3513–7. https://doi.org/10.1128/AAC.00167-13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Alastruey-Izquierdo A, Alcazar-Fuoli L, Rivero-Menendez O, Ayats J, Castro C, Garcia-Rodriguez J, et al. Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study). Antimicrob Agents Chemother. 2018;62(9):e00358-18. https://doi.org/10.1128/AAC.00358-18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Jensen RH, Hagen F, Astvad KM, Tyron A, Meis JF, Arendrup MC. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes. Clin Microbiol Infect. 2016;22(6):570-e1-9. https://doi.org/10.1016/j.cmi.2016.04.001.

    Article  PubMed  Google Scholar 

  45. Risum M, Hare RK, Gertsen JB, Kristensen L, Johansen HK, Helweg-Larsen J, et al. Azole-resistant Aspergillus fumigatus among Danish cystic fibrosis patients: increasing prevalence and dominance of TR(34)/L98H. Front Microbiol. 2020;11:1850. https://doi.org/10.3389/fmicb.2020.01850.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Nawrot U, Kurzyk E, Arendrup MC, Mroczynska M, Wlodarczyk K, Sulik-Tyszka B, et al. Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles. Med Mycol. 2018;56(1):121–4. https://doi.org/10.1093/mmy/myx012.

    Article  CAS  PubMed  Google Scholar 

  47. Goncalves P, Melo A, Dias M, Almeida B, Caetano LA, Verissimo C, et al. Azole-resistant Aspergillus fumigatus harboring the TR(34)/L98H mutation: first reporT in Portugal in environmental samples. Microorganisms. 2020;9(1):57. https://doi.org/10.3390/microorganisms9010057.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Sabino R, Goncalves P, Martins Melo A, Simoes D, Oliveira M, Francisco M, et al. Trends on Aspergillus Epidemiology-Perspectives from a National Reference Laboratory Surveillance Program. J Fungi (Basel). 2021;7(1):28. https://doi.org/10.3390/jof7010028.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Buil JB, Snelders E, Denardi LB, Melchers WJG, Verweij PE. Trends in azole resistance in Aspergillus fumigatus, the Netherlands, 1994–2016. Emerg Infect Dis. 2019;25(1):176–8. https://doi.org/10.3201/eid2501.171925.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Amorim A, Guedes-Vaz L, Araujo R. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy. Int J Antimicrob Agents. 2010;35(4):396–9. https://doi.org/10.1016/j.ijantimicag.2009.12.007.

    Article  CAS  PubMed  Google Scholar 

  51. Seufert R, Sedlacek L, Kahl B, Hogardt M, Hamprecht A, Haase G, et al. Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany. J Antimicrob Chemother. 2018;73(8):2047–53. https://doi.org/10.1093/jac/dky147.

    Article  CAS  PubMed  Google Scholar 

  52. Lavergne RA, Morio F, Danner-Boucher I, Horeau-Langlard D, David V, Hagen F, et al. One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance. J Antimicrob Chemother. 2019;74(7):1884–9. https://doi.org/10.1093/jac/dkz144.

    Article  CAS  PubMed  Google Scholar 

  53. Burgel PR, Baixench MT, Amsellem M, Audureau E, Chapron J, Kanaan R, et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother. 2012;56(2):869–74. https://doi.org/10.1128/AAC.05077-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Sewell TR, Zhang Y, Brackin AP, Shelton JMG, Rhodes J, Fisher MC. Elevated prevalence of azole-resistant Aspergillus fumigatus in urban versus rural environments in the United Kingdom. Antimicrob Agents Chemother. 2019;63(9):e00548-19. https://doi.org/10.1128/AAC.00548-19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Resendiz-Sharpe A, Dewaele K, Merckx R, Bustamante B, Vega-Gomez MC, Rolon M, et al. Triazole-resistance in environmental Aspergillus fumigatus in Latin American and African countries. J Fungi (Basel). 2021;7(4):292. https://doi.org/10.3390/jof7040292.

    Article  CAS  PubMed  Google Scholar 

  56. Duong TN, Le TV, Tran KH, Nguyen PT, Nguyen BT, Nguyen TA, et al. Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type. Environ Microbiol. 2021;23(12):7632–42. https://doi.org/10.1111/1462-2920.15660.. Large environmental sampling study that reported a very high rate of azole resistant Aspergillus in Vietnam, highlighting this area as a hotspot for azole resistance.

    Article  CAS  PubMed  Google Scholar 

  57. Chowdhary A, Kathuria S, Xu J, Sharma C, Sundar G, Singh PK, et al. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR(3)(4)/L98H mutations in the cyp51A gene in India. PLoS One. 2012;7(12):e52871 10.1371/journal.pone.0052871.

    Article  Google Scholar 

  58. Schoustra SE, Debets AJM, Rijs A, Zhang J, Snelders E, Leendertse PC, et al. Environmental hotspots for azole resistance selection of Aspergillus fumigatus, the Netherlands. Emerg Infect Dis. 2019;25(7):1347–53. https://doi.org/10.3201/eid2507.181625.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Glampedakis E, Cassaing S, Fekkar A, Dannaoui E, Bougnoux ME, Bretagne S, et al. Invasive Aspergillosis due to aspergillus section usti: a multicenter retrospective study. Clin Infect Dis. 2021;72(8):1379–85. https://doi.org/10.1093/cid/ciaa230.

    Article  PubMed  Google Scholar 

  60. Pham CD, Reiss E, Hagen F, Meis JF, Lockhart SR. Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011–2013. Emerg Infect Dis. 2014;20(9):1498–503. https://doi.org/10.3201/eid2009.140142.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Wiederhold NP, Gil VG, Gutierrez F, Lindner JR, Albataineh MT, McCarthy DI, et al. First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States. J Clin Microbiol. 2016;54(1):168–71. https://doi.org/10.1128/JCM.02478-15.

    Article  CAS  PubMed  Google Scholar 

  62. Berkow EL, Nunnally NS, Bandea A, Kuykendall R, Beer K, Lockhart SR. Detection of TR(34)/L98H CYP51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the United States from 2015 to 2017. Antimicrob Agents Chemother. 2018;62(5):e02240-17. https://doi.org/10.1128/AAC.02240-17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Hurst SF, Berkow EL, Stevenson KL, Litvintseva AP, Lockhart SR. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA. J Antimicrob Chemother. 2017;72(9):2443–6. https://doi.org/10.1093/jac/dkx168.

    Article  CAS  PubMed  Google Scholar 

  64. Cheng MP, Lawandi A, Lee TC, Dufresne PJ, Seidel D, Verweij PE, et al. Triazole antifungal susceptibilITY patterns among Aspergillus species in Quebec, Canada. J Clin Microbiol. 2019;57(6):e00404-19. https://doi.org/10.1128/JCM.00404-19.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Parent-Michaud M, Dufresne PJ, Fournier E, Folch B, Martineau C, Moreira S, et al. Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013. J Antimicrob Chemother. 2020;75(4):849–58. https://doi.org/10.1093/jac/dkz534.

    Article  CAS  PubMed  Google Scholar 

  66. Ashu EE, Kim GY, Roy-Gayos P, Dong K, Forsythe A, Giglio V, et al. Limited evidence of fungicide-driven triazole-resistant Aspergillus fumigatus in Hamilton. Canada Can J Microbiol. 2018;64(2):119–30. https://doi.org/10.1139/cjm-2017-0410.

    Article  CAS  PubMed  Google Scholar 

  67. Gonzalez-Lara MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, Valenzuela MO, Ponce-de-Leon A, et al. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico. J Antimicrob Chemother. 2019;74(7):2047–50. https://doi.org/10.1093/jac/dkz121.

    Article  CAS  PubMed  Google Scholar 

  68. Romero M, Messina F, Marin E, Arechavala A, Depardo R, Walker L, et al. Antifungal resistance in clinical isolates of Aspergillus spp.: when local epidemiology breaks the norm. J Fungi (Basel). 2019;5(2):41. https://doi.org/10.3390/jof5020041.

    Article  CAS  PubMed  Google Scholar 

  69. Bustamante B, Illescas LR, Posadas A, Campos PE. Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru. Med Mycol. 2020;58(1):54–60. https://doi.org/10.1093/mmy/myz032.

    Article  CAS  PubMed  Google Scholar 

  70. Negri CE, Goncalves SS, Sousa ACP, Bergamasco MD, Martino MDV, Queiroz-Telles F, et al. Triazole resistance is still not emerging in Aspergillus fumigatus isolates causing invasive Aspergillosis in Brazilian patients. Antimicrob Agents Chemother. 2017;61(11):e00608-17. https://doi.org/10.1128/AAC.00608-17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Alvarez-Moreno C, Lavergne RA, Hagen F, Morio F, Meis JF, Le Pape P. Azole-resistant Aspergillus fumigatus harboring TR(34)/L98H, TR(46)/Y121F/T289A and TR(53) mutations related to flower fields in Colombia. Sci Rep. 2017;7:45631. https://doi.org/10.1038/srep45631.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Alvarez-Moreno C, Lavergne RA, Hagen F, Morio F, Meis JF, Le Pape P. Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia. South America Mycologia. 2019;111(2):217–24. https://doi.org/10.1080/00275514.2018.1557796.

    Article  CAS  PubMed  Google Scholar 

  73. Zhang M, Feng CL, Chen F, He Q, Su X, Shi Y. Triazole resistance in Aspergillus fumigatus clinical isolates obtained in Nanjing. China Chin Med J (Engl). 2017;130(6):665–8. https://doi.org/10.4103/0366-6999.201609.

    Article  CAS  PubMed  Google Scholar 

  74. Tashiro M, Izumikawa K, Minematsu A, Hirano K, Iwanaga N, Ide S, et al. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki. Japan Antimicrob Agents Chemother. 2012;56(1):584–7. https://doi.org/10.1128/AAC.05394-11.

    Article  CAS  PubMed  Google Scholar 

  75. Hagiwara D, Takahashi H, Fujimoto M, Sugahara M, Misawa Y, Gonoi T, et al. Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan. J Infect Chemother. 2016;22(8):577–9. https://doi.org/10.1016/j.jiac.2016.01.015.

    Article  CAS  PubMed  Google Scholar 

  76. Toyotome T, Hagiwara D, Kida H, Ogi T, Watanabe A, Wada T, et al. First clinical isolation report of azole-resistant Aspergillus fumigatus with TR(34)/L98H-type mutation in Japan. J Infect Chemother. 2017;23(8):579–81. https://doi.org/10.1016/j.jiac.2016.12.004.

    Article  PubMed  Google Scholar 

  77. Tsuchido Y, Tanaka M, Nakano S, Yamamoto M, Matsumura Y, Nagao M. Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan. Med Mycol. 2019;57(8):997–1003. https://doi.org/10.1093/mmy/myz003.

    Article  CAS  PubMed  Google Scholar 

  78. Chen YC, Kuo SF, Wang HC, Wu CJ, Lin YS, Li WS, et al. Azole resistance in Aspergillus species in Southern Taiwan: an epidemiological surveillance study. Mycoses. 2019;62(12):1174–81. https://doi.org/10.1111/myc.13008.

    Article  CAS  PubMed  Google Scholar 

  79. Wu CJ, Liu WL, Lai CC, Chao CM, Ko WC, Wang HC, et al. Multicenter study of azole-resistant Aspergillus fumigatus clinical isolates, Taiwan(1). Emerg Infect Dis. 2020;26(4):804–6. https://doi.org/10.3201/eid2604.190840.

    Article  CAS  PubMed  Google Scholar 

  80. Takazono T, Ito Y, Tashiro M, Nakano Y, Hirayama T, Hosogaya N, et al. Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis. J Infect Chemother. 2021;27(3):537–9. https://doi.org/10.1016/j.jiac.2020.11.027.

    Article  CAS  PubMed  Google Scholar 

  81. Talbot JJ, Subedi S, Halliday CL, Hibbs DE, Lai F, Lopez-Ruiz FJ, et al. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates. J Antimicrob Chemother. 2018;73(9):2347–51. https://doi.org/10.1093/jac/dky187.

    Article  CAS  PubMed  Google Scholar 

  82. van Rhijn N, Denning DW. Is an azole-resistant Aspergillus hotspot emerging in South-East Asia? Environ Microbiol. 2021;23(12):7275–7. https://doi.org/10.1111/1462-2920.15710.

    Article  CAS  PubMed  Google Scholar 

  83. Duong TMN, Nguyen PT, Le TV, Nguyen HLP, Nguyen BNT, Nguyen BPT, et al. Drug-resistant Aspergillus flavus is highly prevalent in the environment of Vietnam: a new challenge for the management of Aspergillosis? J Fungi (Basel). 2020;6(4):296. https://doi.org/10.3390/jof6040296.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Zhou D, Korfanty GA, Mo M, Wang R, Li X, Li H, et al. Extensive genetic diversity and widespread azole resistance in greenhouse populations of Aspergillus fumigatus in Yunnan. China mSphere. 2021;6(1):e00066-21. https://doi.org/10.1128/mSphere.00066-21. Large environmental sampling study that reported a high rate of azole resistant Aspergillus in China, highlighting this area as a hotspot for azole resistance.

    Article  CAS  PubMed  Google Scholar 

  85. Chen Y, Dong F, Zhao J, Fan H, Qin C, Li R, et al. High azole resistance in Aspergillus fumigatus isolates from strawberry fields, China, 2018. Emerg Infect Dis. 2020;26(1):81–9. https://doi.org/10.3201/eid2601.190885.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Nakano Y, Tashiro M, Urano R, Kikuchi M, Ito N, Moriya E, et al. Characteristics of azole-resistant Aspergillus fumigatus attached to agricultural products imported to Japan. J Infect Chemother. 2020;26(10):1021–5. https://doi.org/10.1016/j.jiac.2020.05.008.

    Article  CAS  PubMed  Google Scholar 

  87. Hagiwara D. Isolation of azole-resistant Aspergillus fumigatus from imported plant bulbs in Japan and the effect of fungicide treatment. J Pestic Sci. 2020;45(3):147–50. https://doi.org/10.1584/jpestics.D20-017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Wang HC, Huang JC, Lin YH, Chen YH, Hsieh MI, Choi PC, et al. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan. Environ Microbiol. 2018;20(1):270–80. https://doi.org/10.1111/1462-2920.13988.

    Article  CAS  PubMed  Google Scholar 

  89. Chowdhary A, Kathuria S, Randhawa HS, Gaur SN, Klaassen CH, Meis JF. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother. 2012;67(2):362–6. https://doi.org/10.1093/jac/dkr443.

    Article  CAS  PubMed  Google Scholar 

  90. Chowdhary A, Sharma C, Kathuria S, Hagen F, Meis JF. Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia. Front Microbiol. 2015;6:428. https://doi.org/10.3389/fmicb.2015.00428.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Dabas Y, Xess I, Bakshi S, Mahapatra M, Seth R. Emergence of azole-resistant Aspergillus fumigatus from immunocompromised hosts in India. Antimicrob Agents Chemother. 2018;62(8):e02264-17. https://doi.org/10.1128/AAC.02264-17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Seyedmousavi S, Hashemi SJ, Zibafar E, Zoll J, Hedayati MT, Mouton JW, et al. Azole-resistant Aspergillus fumigatus. Iran Emerg Infect Dis. 2013;19(5):832–4. https://doi.org/10.3201/eid1905.130075.

    Article  PubMed  Google Scholar 

  93. Ener B, Ergin C, Gulmez D, Agca H, Tikvesli M, Aksoy SA, et al. Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study. J Antimicrob Chemother. 2022;77(7):1894–8. https://doi.org/10.1093/jac/dkac125.

    Article  CAS  PubMed  Google Scholar 

  94. Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT, Mousavi B, et al. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses. 2013;56(6):659–63. https://doi.org/10.1111/myc.12089.

    Article  CAS  PubMed  Google Scholar 

  95. Ahangarkani F, Puts Y, Nabili M, Khodavaisy S, Moazeni M, Salehi Z, et al. First azole-resistant Aspergillus fumigatus isolates with the environmental TR(46) /Y121F/T289A mutation in Iran. Mycoses. 2020;63(5):430–6. https://doi.org/10.1111/myc.13064.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Ahmad S, Khan Z, Hagen F, Meis JF. Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait. Environ Res. 2014;133:20–6. https://doi.org/10.1016/j.envres.2014.05.009.

    Article  CAS  PubMed  Google Scholar 

  97. Chowdhary A, Sharma C, van den Boom M, Yntema JB, Hagen F, Verweij PE, et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother. 2014;69(11):2979–83. https://doi.org/10.1093/jac/dku259.

    Article  CAS  PubMed  Google Scholar 

  98. Sharma C, Hagen F, Moroti R, Meis JF, Chowdhary A. Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: is it de novo or environmentally acquired? J Glob Antimicrob Resist. 2015;3(2):69–74. https://doi.org/10.1016/j.jgar.2015.01.005.

    Article  CAS  PubMed  Google Scholar 

  99. Kemoi EK, Nyerere A, Bii CC. Triazole-resistant Aspergillus fumigatus from fungicide-experienced soils in Naivasha subcounty and Nairobi county. Kenya Int J Microbiol. 2018;2018:7147938. https://doi.org/10.1155/2018/7147938.

    Article  CAS  PubMed  Google Scholar 

  100. Assress HA, Selvarajan R, Nyoni H, Ogola HJO, Mamba BB, Msagati TAM. Azole antifungal resistance in fungal isolates from wastewater treatment plant effluents. Environ Sci Pollut Res Int. 2021;28(3):3217–29. https://doi.org/10.1007/s11356-020-10688-1.

    Article  CAS  PubMed  Google Scholar 

  101. Campbell CA, Osaigbovo II, Oladele RO. Triazole susceptibility of Aspergillus species: environmental survey in Lagos, Nigeria and review of the rest of Africa. Ther Adv Infect Dis. 2021;8:20499361211044330. https://doi.org/10.1177/20499361211044330.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Yerbanga IW, Resendiz-Sharpe A, Bamba S, Lagrou K, Nakanabo Diallo S, Rodriguez-Villalobos H, et al. First investigative study of azole-resistant Aspergillus fumigatus in the environment in Burkina Faso. Int J Environ Res Public Health. 2021;18(5):2250. https://doi.org/10.3390/ijerph18052250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Mushi MF, Buname G, Bader O, Gross U, Mshana SE. Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: call for improved diagnosis of fungi in sub-Saharan Africa. BMC Infect Dis. 2016;16(1):464. https://doi.org/10.1186/s12879-016-1796-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nathan P. Wiederhold.

Ethics declarations

Human and Animal Rights

This article does not contain any studies with human or animal subjects performed by the author.

Conflict of Interest

NPW has received grants and non-financial support from Astellas, grants from bioMerieux, grants, personal fees and non-financial support from F2G, grants from Maxwell Biosciences, grants and non-financial support from Mycovia, grants from Sfunga, non-financial support from Cidara, non-financial support from Pfizer, outside the submitted work. All grants to UT Health San Antonio.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wiederhold, N.P. Epidemiology and Prevalence of Azole-Resistant Aspergillus fumigatus: What Is Our Understanding of the Situation?. Curr Fungal Infect Rep 17, 177–187 (2023). https://doi.org/10.1007/s12281-023-00469-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-023-00469-x

Keywords

Navigation